Ethics & Informed Consent: Mixed-Methods Study Design (Spain)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Mixed-Methods Study Design being conducted in Spain, study designs must align with the primary regulatory legislation: Royal Decree 1090/2015 on Clinical Trials. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Comité de Ética de la Investigación con medicamentos (CEIm). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Mixed-Methods Study Design, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Minimal to Moderate Risk

This design integrates numeric survey responses with qualitative feedback. Ethical protocols must describe how databases are bridged securely while protecting identity.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: GRAMMS framework.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Organic Law 3/2018 on Personal Data Protection (LOPDGDD).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Comité de Ética de la Investigación con medicamentos (CEIm) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Upholding patient privacy during this Mixed-Methods Study Design in Spain is guided by the Belmont Report principles for data stewardship. The protocol must outline safe pathways, particularly if any minor deception in psychological research is used in questionnaires. A standardized research study consent form guarantees that all participants are fully informed under informed consent Belmont Report rules. While observational work rarely requires a clinical trial registration, a signed clinical trial agreement contract is required for health networks. These tracking studies do not utilize live animals regulated by the 3rs replacement reduction refinement guidelines. Ethical oversight committees in Spain audit the study's consent registry periodically to verify compliance with national legal statutes.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions